Ken Griffin Neuroone Medical Technologies Corp Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 21,500 shares of NMTC stock, worth $14,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,500
Previous 125,100
82.81%
Holding current value
$14,834
Previous $85,000
77.65%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NMTC
# of Institutions
37Shares Held
14.4MCall Options Held
65.2KPut Options Held
0-
Bleichroeder LP New York, NY4MShares$2.76 Million0.95% of portfolio
-
Sio Capital Management, LLC New York, NY2.36MShares$1.63 Million0.73% of portfolio
-
Bard Associates Inc Chicago, IL1.85MShares$1.28 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$1.09 Million0.0% of portfolio
-
Perkins Capital Management Inc1.47MShares$1.01 Million1.29% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $11.2M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...